stage heart failure
Reversal of end stage heart failure in juvenile hemochromatosis with iron chelation therapy: a case report
... This case demonstrates that although rare, juvenile hemochromatosis should be suspected in patients who present with hypogonadotropic hypogonadism, diabetes mellitus, or cardiomyopathy without a clear cause. It also ...
6
Systemic inflammation in dogs with advanced-stage heart failure
... of heart failure by the immune system acting as a modulator of myocyte injury and inflammatory reactions contributing to the structural and functional deterioration observed in failing human hearts ...in ...
9
Myostatin and IGF I signaling in end stage human heart failure: a qRT PCR study
... of heart failure as an important compensatory mechanism; however, conflicting data exist in the literature with both down- and upregulated IGF-I levels in end-stage heart failure ...of ...
9
Do Continuous Flow LVADS Improve Diastolic Dysfunction?
... of heart failure, left ventricular assist device (LVAD) therapy has evolved as an integral component of advanced heart failure ...end-stage heart failure ...
7
Does Type of Dialysis Affect BNP in Fluid Overload Patients?
... Coronary heart disease incidence in dialysis patients increases with age, male sex, diabetes, hypertension, increased hs-CRP levels, hyperhomocysteinemia, smoking, time on HD and inadequacy of HD (Soubassi LP et ...
6
Prognostic Factors for Acute Heart Failure (AHF) in the Cardiology Intensive Care Unit (ICU) of the University Hospital Point G (UH Pt G)
... Oumar, B.H., Ibrahima, S., Karamba, T., Souleymane, C., Karim, S.A., Alfousseyni, C., Nouhoum, D., Samba, S., Adama, D., Ichaka, M., Bella, D.I. and Abdoulaye, D.B. (2019) Prognostic Factors for Acute Heart ...
9
Congestive Heart Failure: Current Treatment and Therapies under Realm of Research
... the heart muscle of patients with HF, CoQ10 levels are decreased and the deficiency becomes more pronounced when the severity of HF get worsen ...with heart failure without any side effects ...
8
A framework for clinical reasoning in adult cardiology
... specific heart murmurs and pericardial rub or knock (that directly gives the diagnosis), most of the physical signs are also nonspecific (jugular venous pressure, carotid pulse, gallops, pulmonary rales, ankle ...
7
Northern Territory Heart Failure Initiative–Clinical Audit (NTHFI–CA)–a prospective database on the quality of care and outcomes for acute decompensated heart failure admission in the Northern Territory: study design and rationale
... the stage of HF; have fewer clinical inter- ventions and support compared with their urban coun- terparts; are less likely to receive novel therapeutic options or enrolled in multicentre trials; and are more ...
14
Clinical and Echo Profile in Heart Failure with preserved ejection fraction
... diastolic heart failure because they enhance SR function, promote more rapid and complete relaxation, increase splanchnic blood flow, increase venous capacitance, and facilitate ...raise heart rate, ...
102
Association of serum calcium and heart failure with preserved ejection fraction in patients with type 2 diabetes
... The potential mechanisms underlying association between serum calcium and HFpEF remains unclear; however, there are some possibilities. On the one hand, the elevation of serum calcium appears to function as a connecting ...
9
Hand-held cardiac ultrasound examinations performed in primary care patients by nonexperts to identify reduced ejection fraction
... indicating heart failure (HF) could benefit from faster diagnostic pro- cedures that are conducted at the point of ...renal failure, atrial fibrillation, and advanced age), natriuretic peptide levels ...
9
Candesartan in heart failure
... Abstract: Candesartan cilexetil is a nonpeptide selective blocker of the angiotensin II receptor sub-type 1. It is a prodrug that is converted to its active metabolite during its variable absorption. It is highly protein ...
10
PHARMACOTHERAPY OF HEART FAILURE
... Research and trials in previous 30 years have confirmed the usefulness of β1-blockers (primarily bisoprolol, metoprolol, nebivolol) and carvedilol in patients of mild-to-moderate symptomatic CHF who were treated by ACE ...
10
Study on Lipid Abnormalities in Chronic Renal Failure
... dyslipidemia appears to be independent of the underlying renal disease and may substantially contribute to the increased cardiovascular risk that has been observed in these individuals as well as to the progression of ...
95
New pharmacological and technological management strategies in heart failure
... a heart failure hospitalization in the past 12 ...in heart failure-related hospitalizations over the 6-month time periods and a 37% decrease during the entire follow-up period (Figure ...first ...
11
The experience of receiving successive diagnoses for people with multiple chronic health conditions including stage 3 heart failure
... My commitment to the topic is shown by my long-term interest in the experiences of those who are life limited, more recently through my firsthand experience of working as a placement trainee counselling psychologist in a ...
243
Pharmacotherapy of Chronic Heart Failure
... Diastolic Heart Failure) investigated the influence of spironolactone 25 mg 12-month therapy in comparison with placebo in 422 patients with CHFpEF on the /’ parameter and tolerance of physical loads with ...
22
Prognostic significance of Serum Uric Acid Level in Patients with Acute Myocardial Infarction
... In the current issue of circulation, Anker and Colleagues 54 report that elevated levels of uric acid predict mortality and the need for heart transplantation in patients with congestive heart ...
92
Copeptin in heart failure
... r= 0.276, P,0.001; LVEF, r=− 0.188, P= 0.03) and follow-up (WMIS, r= 0.244, P,0.001; LVEF, r=− 0.270, P,0.001). It also correlated with ventricular volumes (left ventricular end systolic volume [LVESV]/diastolic volume ...
12